Please login to the form below

Not currently logged in
Email:
Password:

IGEM Therapeutics appoints Dr Tim Wilson as CEO

He joins after the UK immuno-oncology firm raises £2m to advance its pipeline

Tim WilsonUK-based immuno-oncology company IGEM - a spin-out of King’s College London - has appointed Dr Tim Wilson as its new chief executive officer at a time when the company has raised £2m from Epidarex Capital, in order to progress its pipeline of IgE antibody drug candidates.

Wilson has over 28 years’ experience in the life sciences sector, ranging from venture capital and start-ups to investment banking and equity research.

He said: “The raising of £2m in series A finding is a testament to the compelling research results generated by Dr Karagiannis and her team at King’s College London.

“I look forward to leading the company as we create important new therapies for the treatment of cancer.”

Wilson has worked for numerous private and public life science companies in the US and Europe at all stages of development, from start-ups to industry leaders.

Dr Peter Finan, venture partner and Epidarex Capital, said: “We are very pleased to have been able to recruit Dr Tim Wilson to lead IGEM as CEO.

“We look forward to working with IGEM to realise their potential.”

21st June 2017

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics